Pharmaceuticals

Physiotherapy at Home Market Size, Share & Trends Analysis Distribution by Type (Musculoskeletal Therapy, Cardiopulmonary Therapy, Neurological Therapy, Pediatric Therapy, and Geriatric Therapy), Equipment Type (Electrical Stimulators, Wearable Devices, and Exercise Equipment), Service Mode (In-Person Home Visits and Tele-Rehabilitation), Application (Chronic Pain Management, Post-Surgical Recovery, Sports Injury Rehabilitation, and Mobility Impairment), and By Segments Forecasts, 2025-2034

Global Physiotherapy at Home Market Size is valued at US$ 15.5 Bn in 2024 and is predicted to reach US$ 28.7 Bn by the year 2034 at an 6.7% CAGR during the forecast period for 2025-2034. A medical service called "physiotherapy at home" offers patients expert physical therapy services in the convenience of their own homes. Certified physiotherapists evaluate, diagnose, and treat a range of physical ailments, including musculoskeletal injuries, ne...

Report ID: 3272  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Cefepime Market Size, Share & Trends Analysis Distribution by Type (Oral Formulations, Injectable, and Combination Therapies), Application (Pneumonia, Meningitis, Urinary Tract Infections, Bloodstream Infections, Skin and Soft Tissue Infections, and Intra-abdominal Infections), Distribution Channel (Hospital Pharmacies and Retail Pharmacies), and By Segments Forecasts, 2025-2034

Global Cefepime Market is valued at US$ 2.0 Bn in 2024 and it is expected to reach US$ 3.86 Bn by 2034, with a CAGR of 7.0% during the forecast period of 2025-2034. Cefepime, a fourth-generation cephalosporin antibiotic, serves as a fundamental agent in the treatment of severe bacterial infections within hospital environments. Its mechanism of action entails the inhibition of bacterial cell wall synthesis, resulting in the elimination of suscept...

Report ID: 3274  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Nucleotide Sugar Synthesis Services Market Size, Share & Trends Analysis Distribution, By Type (Small-Scale Synthesis, Medium-Scale Synthesis, and Large-Scale Synthesis), By Product Type (Uridine Diphosphate (UDP) Sugars, Cytidine Monophosphate (CMP) Sugars, Guanosine Diphosphate (GDP) Sugars, and Others), By Application (Vaccine Preparation, Drug Research & Development (R&D), Genetic Engineering and Cell Therapy, Diagnostics, and Academic Research), and Segment Forecasts, 2025-2034

Global Nucleotide Sugar Synthesis Services Market Size is valued at US$ 440.0 Mn in 2024 and is predicted to reach US$ 1,306.2 Mn by the year 2034 at an 11.7% CAGR during the forecast period for 2025-2034. Nucleotide sugar synthesis services include a range of products designed to meet specific client requirements. Custom synthesis of different nucleotide sugars, including those with modifications or artificial connections, is one of these. To e...

Report ID: 3275  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 170

Radiopharmaceuticals Market Size, Share & Trends Analysis Report By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Radioisotope (Technetium-99m, Fluorine-18, Iodine-131, Lutetium-177, Yttrium-90, Gallium-67, Gallium-68, Rubidium-82, Iodine-123, Iodine-125, Indium-111 ,Other Isotopes), By Technology / Modality (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals, Beta-emitting Radiopharmaceuticals , Alpha-emitting Radiopharmaceuticals), By Indication (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Other Indications), By Source, By End User and By Segments Forecasts, 2025-2034

Global Radiopharmaceuticals Market Size is valued at USD 6.2 Bn in 2024 and is predicted to reach USD 19.6 Bn by the year 2034 at a 12.7% CAGR during the forecast period for 2025-2034. Radiopharmaceuticals are medications that incorporate radioactive isotopes. These chemicals are utilized in the field of nuclear medicine for diagnostic and therapeutic applications. They produce detectable radiation that may be captured in images, enabling health...

Report ID: 2290  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 179

Nanocarrier Drug Delivery Market Size, Share & Trends Analysis Distribution By Type (Liposomes, Nanocrystals, Polymeric Nanoparticles, Nanotubes, Dendrimers, Solid Lipid Nanoparticles, Micelles, and Quantum Dots), By Route of Administration (Oral, Pulmonary, Intravenous, and Transdermal), By Application (Oncology, Neurology, Pulmonary, Diabetes, Infectious Diseases, Cardiovascular, Ophthalmology, and Immunology), By End-use (Hospitals, CROs, and Pharma & Biotech Companies), and By Segments Forecasts, 2025-2034

Global Nanocarrier Drug Delivery Market Size is valued at US$ 10.7 Bn in 2024 and is predicted to reach US$ 49.5 Bn by the year 2034 at an 17.3% CAGR during the forecast period for 2025-2034. Nanocarrier drug delivery refers to the use of ultra-small, engineered particles typically ranging from 1 to 100 nanometers to transport therapeutic agents directly to specific tissues or cells. These nanocarriers, made from lipids, polymers, metals, or cer...

Report ID: 3268  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Egg Cell Cryopreservation Service Market Size, Share & Trends Analysis Distribution by Type (Oocyte Cryopreservation and Egg Banking Services), Application (Medical Egg Freezing and Elective Egg Freezing), End-use (Fertility Clinics and Hospitals), and By Segments Forecasts, 2025-2034

Global Egg Cell Cryopreservation Service Market is valued at US$ 1.30 Bn in 2024 and it is expected to reach US$ 3.37 Bn by 2034, with a CAGR of 10.2% during the forecast period of 2025-2034. Egg cell cryopreservation, commonly known as egg freezing, is a clinical process involving the retrieval, freezing, and storage of a woman’s mature oocytes for future reproductive use. The procedure begins with ovarian stimulation through hormone inje...

Report ID: 3269  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Direct Primary Care Market Share & Trends Analysis Report By Type (Clinical services, Telehealth services, Laboratory services, Consultative services, Others (Vaccinations and immunization visits, etc.)), By Care Setting (Office-based DPC practices, Home-based DPC practices, Telehealth-only DPC practices, Hybrid DPC practices), By Enrollment Channel (Direct-to-consumer, Employer group contracts, Associations/unions and other group plans), By End User, By Region, and Segment Forecasts, 2025-2034

Global Direct Primary Care Market Size is valued at USD 59.5 Bn in 2024 and is predicted to reach USD 92.9 Bn by the year 2034 at an 4.6% CAGR during the forecast period for 2025-2034. Direct Primary Care (DPC) represents an innovative primary care practice model where patients gain unlimited access to a range of primary care services by paying a monthly membership fee specific to each practice. This model stands out as a bottom-up, physician-dr...

Report ID: 2559  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Pharmaceutical Pellets Market Size, Share & Trends Analysis Report By Pellet Type (Sugar spheres (non-pareils), lline cellulose (MCC) spheres, Others), By Manufacturing Technology ( Solution & Suspension Layering , Dry Powder Layering, Extrusion–Spheronization, Fluid-Bed Granulation/Pelletization, Spray Congealing / Hot-Melt, Spray Drying), By Mechanism of Action (Diffusion, Erosion, Osmosis), By Dosage (Pellets , Tablets, Sachets, Others), By End Use, By Region and By Segment Forecasts, 2025-2034

Global Pharmaceutical Pellets Market Size is valued at USD 2.1 Billion in 2024 and is predicted to reach USD 6.0 Billion by the year 2034 at a 10.9% CAGR during the forecast period for 2025-2034. Pellets or granules are free-flowing units created by agglomeration processes in capsules. Fine powders are transformed into fine particles using agglomeration processes. Compared to alternative dosage forms, these particles have various advantages, inc...

Report ID: 1836  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Necrotizing Fasciitis Market Size, Share & Trends Analysis Distribution, by Type (Type I (Polymicrobial), Type II (Monomicrobial), and Type III (Gas gangrene / clostridial myonecrosis)), by Treatment (Empiric Broad-Spectrum Antibacterials, MRSA-coverage Add-Ons, Antitoxin Adjunct For Invasive GAS, Pathogen-targeted Antibacterial Regimens, Antifungals For Necrotizing Fungal Infections, and Immunotherapies), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Segment Forecasts, 2025-2034

Global Necrotizing Fasciitis Market is valued at US$ 1.0 Bn in 2024 and it is expected to reach US$ 2.16 Bn by 2034, with a CAGR of 8.2% during the forecast period of 2025-2034. Necrotizing fasciitis is an anchor for critical care pathways and interventions across healthcare systems. Its therapy encourages prompt diagnosis, LRINEC-guided triage, early urgent surgical investigation, and repeated debridement to avoid mortality and limb loss. Care ...

Report ID: 3263  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180

Pharmaceutical Cleanroom Bag Market Size, Share & Trends Analysis Distribution By Type (Liner Bags, Sterile Bags, and Zipper Bags), By Material Type (Nylon, Polyethylene (PE), Polypropylene (PP), and Others), By Application (API Storage & Transport, Finished Product Packaging, Waste Disposal, and Equipment Covers), and Segment Forecasts, 2025-2034

Pharmaceutical Cleanroom Bag Market Size is valued at US$ 1.5 Bn in 2024 and is predicted to reach US$ 3.3 Bn by the year 2034 at an 8.3% CAGR during the forecast period for 2025-2034. Pharmaceutical cleanroom bags are essential for maintaining aseptic conditions during pharmaceutical production. Sensitive pharmaceutical products are transported, dangerous materials are contained, and sterile components are packaged, among other uses. Througho...

Report ID: 3264  |  

Delivery: Immediate  |  

Published: November 2025   |  

No. of Pages: 180